Rizonib 250mg Crizotinib

Category:

Description

Rizonib 250mg crizotinib is a targeted therapy that blocks the growth of cancer cells in metastatic non-small cell lung cancer (NSCLC).

Reviews

There are no reviews yet.

Be the first to review “Rizonib 250mg Crizotinib”

Your email address will not be published. Required fields are marked *